NasdaqCM - Delayed Quote USD

PharmaCyte Biotech, Inc. (PMCB)

1.1100
+0.0200
+(1.83%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
4,502.2140
6,520.0080
6,455.4940
4,392.0140
3,622.9810
Operating Income
-4,502.2140
-6,520.0080
-6,455.4940
-4,392.0140
-3,622.9810
Net Non Operating Interest Income Expense
1,932.7840
3,398.8190
1,937.4990
157.1360
-3.0460
Other Income Expense
22,822.5990
3,454.9520
202.0020
-4.2830
74.7910
Pretax Income
20,253.1690
333.7630
-4,315.9930
-4,239.1610
-3,551.2360
Net Income Common Stockholders
9,975.0300
-17,237.4030
-4,315.9930
-4,239.1610
-3,551.2360
Diluted NI Available to Com Stockholders
9,975.0300
-17,237.4030
-4,315.9930
-4,239.1610
-3,551.2360
Basic EPS
1.34
-1.80
-0.22
-0.27
-2.45
Diluted EPS
1.34
-1.80
-0.22
-0.27
-2.45
Basic Average Shares
7,703.4240
9,581.0590
19,489.2040
15,521.6540
1,448.2850
Diluted Average Shares
7,703.4240
9,581.0590
19,489.2040
15,521.6540
1,448.2850
Total Operating Income as Reported
-6,502.2140
-8,520.0080
-6,455.4940
-4,392.0140
-3,622.9810
Total Expenses
4,502.2140
6,520.0080
6,455.4940
4,392.0140
3,622.9810
Net Income from Continuing & Discontinued Operation
20,253.1690
333.7630
-4,315.9930
-4,239.1610
-3,551.2360
Normalized Income
8,681.3056
396.3255
-4,315.9930
-4,239.1610
-3,627.2150
Interest Income
1,932.7840
3,398.8190
1,937.4990
157.6450
0
Interest Expense
0
--
0
0.5090
3.0460
Net Interest Income
1,932.7840
3,398.8190
1,937.4990
157.1360
-3.0460
EBIT
-4,502.2140
-6,520.0080
-6,455.4940
-4,238.6520
-3,548.1900
EBITDA
-4,502.2140
-6,520.0080
-6,455.4940
-4,238.6520
-3,548.1900
Net Income from Continuing Operation Net Minority Interest
20,253.1690
333.7630
-4,315.9930
-4,239.1610
-3,551.2360
Total Unusual Items Excluding Goodwill
19,286.4390
-79.1930
0
0
75.9790
Total Unusual Items
19,286.4390
-79.1930
0
0
75.9790
Normalized EBITDA
-23,788.6530
-6,440.8150
-6,455.4940
-4,238.6520
-3,624.1690
Tax Rate for Calcs
0.0004
0.0002
0
0
0
Tax Effect of Unusual Items
7,714.5756
-16.6305
0
0
0
4/30/2021 - 1/2/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STAB Statera Biopharma, Inc.
0.0001
0.00%
 
APTOF Aptose Biosciences Inc.
1.6500
0.00%
 
OVID Ovid Therapeutics Inc.
0.2901
-1.33%
 
NGNE Neurogene Inc.
14.73
-1.80%
 
NRXS NeurAxis, Inc.
2.0000
-8.26%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
NEXI NexImmune, Inc.
0.0001
0.00%
 
CELZ Creative Medical Technology Holdings, Inc.
2.1400
+2.88%
 
ICU SeaStar Medical Holding Corporation
1.2450
+0.40%
 
PHGE BiomX Inc.
0.5160
-7.38%